Manufacturer record
Mankind Pharma Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Mankind Pharma Ltd (Sikkim) were declared Not of Standard Quality between September 2023 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Mankind Pharma Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amlodipine & Atenolol Tablets IP | G65Y010Mfg 2025-01 · Exp 2026-12 | The sample does not conform to I.P. w.r.to the tests for Identification and AssayAssay | SDTL, GuwahatiState lab | Jun 2026 |
| Telmisartan & Hydrochlorothizide Tablets IP | B25X021Mfg 2024-12 · Exp 2026-11 | test for Dissolution of Telmisartan onlyDissolution | RDTL, Hubli, KarnatakaState lab | Nov 2025 |
| Rabeprazole Gastro- Resistant Tablets I.P. (RABEKIND-20) | H2IAV013Mfg 2022-11 · Exp 2024-10 | Dissolution of Rabeprazole Sodium in Acid PhaseDissolution | RDTL GuwahatiState lab | Sep 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.